Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pseudophakic Cystoid Macular Edema Prevention and Risk Factors; Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo

NCT03025945 is registered in ClinicalTrials.gov with Intuor Technologies, Inc. as lead sponsor.

NCT NCT03025945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03025945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pseudophakic Cystoid Macular Edema Prevention and Risk Factors; Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo
Lead sponsor
Intuor Technologies, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2013
Completion date
January 31, 2017
Enrollment
662 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cystoid macular edema